<VariationArchive RecordType="classified" VariationID="917507" VariationName="NM_003483.6(HMGA2):c.303del (p.Ser102fs)" VariationType="Deletion" Accession="VCV000917507" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-03-05" DateCreated="2020-06-15" MostRecentSubmission="2023-03-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="905836" VariationID="917507">
      <GeneList>
        <Gene Symbol="HMGA2" FullName="high mobility group AT-hook 2" GeneID="8091" HGNC_ID="HGNC:5009" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="65824460" stop="65966291" display_start="65824460" display_stop="65966291" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="66218239" stop="66360070" display_start="66218239" display_stop="66360070" Strand="+" />
          </Location>
          <OMIM>600698</OMIM>
          <Haploinsufficiency last_evaluated="2021-09-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HMGA2">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-09-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HMGA2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003483.6(HMGA2):c.303del (p.Ser102fs)</Name>
      <CanonicalSPDI>NC_000012.12:65963263:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="65963264" stop="65963264" display_start="65963264" display_stop="65963264" variantLength="1" positionVCF="65963263" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="66357044" stop="66357044" display_start="66357044" display_stop="66357044" variantLength="1" positionVCF="66357043" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>S102fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.66357045del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.66357045del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.65963265del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.65963265del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016296.1" sequenceAccession="NG_016296" sequenceVersion="1" change="g.143806del">
            <Expression>NG_016296.1:g.143806del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003483.6" sequenceAccession="NM_003483" sequenceVersion="6" change="c.303del" MANESelect="true">
            <Expression>NM_003483.6:c.303del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003474.1" sequenceAccession="NP_003474" sequenceVersion="1" change="p.Ser102fs">
            <Expression>NP_003474.1:p.Ser102fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600698.0004" DB="OMIM" />
        <XRef Type="rs" ID="1876805546" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003483.6(HMGA2):c.303del (p.Ser102fs) AND Silver-Russell syndrome 5" Accession="RCV001174520" Version="1">
        <ClassifiedConditionList TraitSetID="53795">
          <ClassifiedCondition DB="MedGen" ID="C5394456">Silver-Russell syndrome 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-06-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003483.6(HMGA2):c.303del (p.Ser102fs) AND not provided" Accession="RCV001751307" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-07-17" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-07-17" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-06-15" MostRecentSubmission="2023-03-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">29453418</ID>
        </Citation>
        <DescriptionHistory Dated="2021-11-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="53795" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="53373" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Silver-Russell syndrome 5</ElementValue>
                <XRef ID="MONDO:0020795" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SRS5</ElementValue>
                <XRef Type="MIM" ID="618908" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Silver-Russell Syndrome (SRS) is typically characterized by asymmetric gestational growth restriction resulting in affected individuals being born small for gestational age, with relative macrocephaly at birth (head circumference =1.5 SD above birth weight and/or length), prominent forehead usually with frontal bossing, and frequently body asymmetry. This is followed by postnatal growth failure, and in some cases progressive limb length discrepancy and feeding difficulties. Additional clinical features include triangular facies, fifth-finger clinodactyly, and micrognathia with narrow chin. Except for the limb length asymmetry, the growth failure is proportionate and head growth normal. The average adult height in untreated individuals is ~3.1±1.4 SD below the mean. The Netchine-Harbison Clinical Scoring System (NH-CSS) is a sensitive diagnostic scoring system. Clinical diagnosis can be established in an individual who meets at least four of the NH-CSS clinical criteria – prominent forehead/frontal bossing and relative macrocephaly at birth plus two additional findings – and in whom other disorders have been ruled out.</Attribute>
                <XRef ID="NBK1324" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301499</ID>
                <ID Source="BookShelf">NBK1324</ID>
              </Citation>
              <XRef ID="C5394456" DB="MedGen" />
              <XRef ID="MONDO:0020795" DB="MONDO" />
              <XRef Type="MIM" ID="618908" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2644828" SubmissionDate="2020-06-12" DateLastUpdated="2020-06-15" DateCreated="2020-06-15">
        <ClinVarSubmissionID localKey="600698.0004_SILVER-RUSSELL SYNDROME 5" title="HMGA2, 1-BP DEL, 303C_SILVER-RUSSELL SYNDROME 5" />
        <ClinVarAccession Accession="SCV001337660" DateUpdated="2020-06-15" DateCreated="2020-06-15" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 10.5-year-old boy (case 1096) with Silver-Russell syndrome (SRS5; 618908), Costain et al. (2018) identified heterozygosity for a 1-bp deletion (c.303delC) in exon 5 of the HMGA2 gene, causing a frameshift predicted to result in a premature termination codon (Ser102HisfsTer64). The mutation was inherited from his affected mother.</Attribute>
              <Citation>
                <ID Source="PubMed">29453418</ID>
              </Citation>
              <XRef DB="OMIM" ID="618908" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HMGA2" />
          </GeneList>
          <Name>HMGA2, 1-BP DEL, 303C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 303C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600698.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SILVER-RUSSELL SYNDROME 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3885956" SubmissionDate="2021-10-30" DateLastUpdated="2023-03-04" DateCreated="2021-11-06">
        <ClinVarSubmissionID localKey="GDXSV:192693" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001988372" DateUpdated="2023-03-04" DateCreated="2021-11-06" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>Not observed in large population cohorts (Lek et al., 2016); Frameshift variant predicted to result in protein truncation as the last 8 amino acids are replaced with 63 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; This variant is associated with the following publications: (PMID: 29453418)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HMGA2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2716144</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003483.4:c.303del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_64_20211030201206</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3885956" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2644828" TraitType="Disease" MappingType="Name" MappingValue="SILVER-RUSSELL SYNDROME 5" MappingRef="Preferred">
        <MedGen CUI="C5394456" Name="Silver-Russell syndrome 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

